Xeris Biopharma Holdings (XERS) Net Equity Issued and Repurchased (2020 - 2026)
Xeris Biopharma Holdings (XERS) recorded Net Equity Issued and Repurchased of $2.13 million in Q2 2026, up 18.4% from $1.8 million a year earlier but down 73.9% from the prior quarter.
Powered by 
Analysis
Xeris Biopharma Holdings (XERS) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends
On a TTM basis, Xeris Biopharma Holdings' Net Equity Issued and Repurchased came in at $25.92 million as of Jun 30, 2026, up 258.6% year-over-year; for FY2025, it came in at $22.27 million.
- Annual Net Equity Issued and Repurchased has a five-year compound annual growth rate of -19.7% (FY2020 to FY2025).
- Across earlier years, Net Equity Issued and Repurchased came in at $1.73 million in FY2024 (+198.3%), $581,000 in FY2023 (-98.1%), $30.84 million in FY2022 (+10.8%) and $27.84 million in FY2021 (-58.3%).
- Quarterly Net Equity Issued and Repurchased has ranged from $1,000 in Q3 2021 to $30.01 million in Q1 2022 over the past five years.
- On a year-over-year basis, Net Equity Issued and Repurchased has increased for three consecutive quarters, with growth averaging 265.1% over the last five quarters.
- Peak year-over-year performance for Net Equity Issued and Repurchased in the last five years was growth of 959.0% in Q1 2025, against a decline of 3.9% in Q4 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $8.18 million (Q1 2026), $1.27 million (Q4 2025) and $14.33 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Xeris Biopharma Holdings | 2.89 Bn | 2.41 Bn | 94.80 Mn | 675,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 675,000.00 |
| Jun 30, 2026 | 2.13 Mn |
| Mar 31, 2026 | 8.18 Mn |
| Dec 31, 2025 | 1.27 Mn |
| Sep 30, 2025 | 14.33 Mn |
| Jun 30, 2025 | 1.80 Mn |
| Mar 31, 2025 | 4.86 Mn |
| Dec 31, 2024 | 564,000.00 |
| Jun 30, 2024 | 710,000.00 |
| Mar 31, 2024 | 459,000.00 |
| Jun 30, 2023 | 581,000.00 |
| Dec 31, 2022 | 318,000.00 |
| Jun 30, 2022 | 510,000.00 |
| Mar 31, 2022 | 30.01 Mn |
| Dec 31, 2021 | 294,000.00 |
| Sep 30, 2021 | 1,000.00 |
| Jun 30, 2021 | 514,000.00 |
| Mar 31, 2021 | 27.03 Mn |
| Dec 31, 2020 | 306,000.00 |
API Access
Xeris Biopharma Holdings Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=XERS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "XERS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=XERS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();